Home › NDC Lookup › Ingredients › Octinoxate, Zinc Oxide › 14141-0360-01
CYZONE STUDIO LOOK MATTE FINISH BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 MEDIO 320C OCTINOXATE, ZINC OXIDE 40 mg/g; 23.5 mg/g Emulsion — NDC 14141-0360-01 package photo

CYZONE STUDIO LOOK MATTE FINISH BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 MEDIO 320C OCTINOXATE, ZINC OXIDE 40 mg/g; 23.5 mg/g Emulsion

by BEL STAR S A · 1 TUBE in 1 BOX (14141-360-01) / 27 g in 1 TUBE
NDC 14141-0360-01
🏷️ FDA NDC (as labeled) 14141-360-01 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 14141-360-01
Product NDC 14141-360
11-digit billing NDC 14141036001
UNII 4Y5P7MUD51, SOI2LOH54Z
Application # M020
SPL Set ID 27c30645-dcef-bc31-e063-6394a90a1368
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-11-25
Route TOPICAL
Dosage form EMULSION
Substance OCTINOXATE; ZINC OXIDE
Why two NDCs? The FDA registers this code as 14141-360-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 14141-0360-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerBEL STAR S A
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code14141
First marketedNov 2024
Product typeHuman Otc Drug
Portfolio70 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Cyzone Studio Look is a topical matte-finish foundation emulsion that functions as a sunscreen product. It contains two ultraviolet (UV) filters: octinoxate and zinc oxide, which are commonly used in sunscreens to help protect skin from UVA and UVB rays. The product is formulated as an emulsion base with high coverage and long-wearing properties, marketed with an SPF 20. As an OTC monograph drug, it is regulated under FDA's established standards for over-the-counter sunscreen products.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Medio Claro 180F 40 mg/g; 23.5 mg/g 14141-0356-01 BEL 1 tube — — FDA listed —
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Claro 140C 40 mg/g; 23.5 mg/g 14141-0355-01 BEL 1 tube — — FDA listed —
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Medio Claro 270C 40 mg/g; 23.5 mg/g 14141-0359-01 BEL 1 tube — — FDA listed —
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Medio 320C 40 mg/g; 23.5 mg/gthis 14141-0360-01 BEL 1 tube — — FDA listed —
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Claro 110C 40 mg/g; 23.5 mg/g 14141-0354-01 BEL 1 tube — — FDA listed —
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Medio Claro 210F 40 mg/g; 23.5 mg/g 14141-0358-01 BEL 1 tube — — FDA listed —
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Medio 380F 40 mg/g; 23.5 mg/g 14141-0362-01 BEL 1 tube — — FDA listed —
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Medio 350N 40 mg/g; 23.5 mg/g 14141-0361-01 BEL 1 tube — — FDA listed —
Cyzone Studio Look Matte Finish Base De Alta Cobertura Y Larga Duracion Fps 20 Medio Claro 200C 40 mg/g; 23.5 mg/g 14141-0357-01 BEL 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2024
On the market since
Nov 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
14141-0360-01 You're viewing this 1 TUBE in 1 BOX (14141-360-01) / 27 g in 1 TUBE 2024-11-25 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 14141-360-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 14141-0360-01, written without dashes as 14141036001. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 14141-0360-01, the first segment (14141) is the labeler code FDA assigned to BEL STAR S A; the middle segment (0360) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by BEL STAR S A. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
BEL STAR S A is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 6 words ▾

Uso Ayuda a prevenir quemaduras solares

⏱️ Dosage and Administration 42 words ▾

Instrucciones Aplicar generosamente y uniformemente 15 minutos antes de la exposición al sol. Reaplicar por lo menos cada dos horas. Use un protector solar resistente al agua si usted nada o suda. Niños menores a 6 meses de edad: Consulte al médico

⚠️ Warnings 113 words ▾

Advertencias Alerta de Cáncer en la piel / envejecimiento de la piel : Pasar tiempo bajo el sol incrementa el riesgo de cáncer y envejecimiento prematuro de la piel. Este producto ha demostrado que unicamente ayuda a prevenir las quemaduras solares pero no previene el cáncer a la piel ni el envejecimiento prematuro de la misma. Sólo para uso externo.

No usar en piel dañada o lastimada. Cuando use este producto mantener alejado de los ojos. Enjuagar con agua para eliminar.

Detenga su uso y consulte al doctor si sucede enrojecimiento. Mantener fuera del alcance de los niños. Si es ingerido obtener ayuda médica o contactar al centro de Control de Envenenamiento inmediatamente

🧪 Active Ingredient 7 words ▾

Ingredientes activos OCTINOXATAE 4.00% ZINC OXIDE 2.35%

🧪 Inactive Ingredients 89 words ▾

Ingredientes inactivos Isododecane, water, dimethicone, mica, trimethylsiloxysilicate, butylene glycol, polymethylsilsesquioxane, octyldodecyl stearoyl stearate, polyglyceryl-3 diisostearate, disteardimonium hectorite, peg/ppg-18/18 dimethicone, polysilicone-11, dimethicone/vinyl dimethicone crosspolymer, lecithin, phenoxyethanol, niacinamide, silica dimethyl silylate, propylene carbonate, triethoxycaprylylsilane, caprylyl glycol, decyl glucoside, silica, chlorphenesin, fragrance, zea mays (corn) starch, glycerin, sucrose palmitate, hydrolyzed soy protein, glyceryl linoleate, tocopheryl acetate, rice amino acids, proline, benzyl alcohol, citric acid, echinacea purpurea callus lysate, hydrolyzed adansonia digitata seed extract, potassium sorbate, sodium hyaluronate, linalool, citrus aurantium peel oil, limonene.

Puede contener : Titanium dioxide, iron oxides, bismuth oxychloride.

🎯 Purpose 3 words ▾

Propósito Protector solar

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 14141-0359-01 · BEL 14141-0361-01 · BEL →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.